📢 Industry Highlights in Biotech & Life Sciences 📢

From leadership changes to licensing deals and product launches, here's a roundup of recent developments shaping the future of healthcare innovation:

Sources

🔗 Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development

🔗 Radiant Biotherapeutics Appoints Deborah Geraghty, Ph.D., as President and Chief Executive Officer

🔗 enGene Announces Board and Leadership Appointments to Support Commercial Readiness

🔗 OTC Markets Group Welcomes Vaxart, Inc. to OTCQX

🔗 UAE Approves BioAro’s Longevity+ Supplement, Signaling Major Market Potential in Global Preventive Health

🔗 Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness

🔗 ImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors

🔗 Life Sciences BC Announces 2025 Awards Winners, Honouring Excellence in Health Innovation

🔗 Newly Elected Directors of Sinovac Hold the First Board Meeting

#biotech #lifesciences #healthcareinnovation #leadership #drugdevelopment #clinicaltrials #biopharma #LinkedInNews

💡 Follow the BioTech Weekly newsletter for more updates on biotech breakthroughs, regulatory milestones, and investment trends in life sciences.

Disclaimer: This podcast includes content generated with the help of large language models (LLM). Although care has been taken to ensure accuracy, LLMs can sometimes produce incorrect or misleading information. Listeners are advised to independently verify any details, provide feedback, and reach out.

🔬 Bioscience Association Manitoba Applauds Government Action to Advance Bioscience Research and Clinical Trials in Manitoba

🤖 ImmunoPrecise Validates LENSai Epitope Mapping Platform Across Broad Range of Unseen Therapeutic Targets Beyond Training Data

👩‍⚕️ Synedgen Promotes Dr. Laura Saward to Chief Executive Officer and Appoints Dr. Kenton Gregory to Chief Medical Officer

🧬 Anne Wojcicki’s nonprofit gets court approval to buy 23andMe for $305 million

💡 Portal Biotech Raises $35 Million Series A, Leveraging AI to Deliver the World’s First Full-Length Single-Molecule Protein Sequencer

🏥 Shriners Children’s to open $153M medical research facility in Atlanta

🚨 Biotech & Pharma Industry Highlights – Latest Announcements 🚨 Here are some recent developments shaping innovation across neuroscience, oncology, mental health, and regenerative medicine:

🔬 New Data for Nusinersen Underscore Biogen’s Commitment to Advancing Clinical Research to Improve Outcomes in SMA Biogen presents new clinical data showing improved motor outcomes with a higher dose of nusinersen in SMA patients.

💊 PSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common Shares C$600,000 raised to support further development of psilocybin-based mental health therapies.

🧬 FDA Grants RMAT Designation for enGene’s Detalimogene A significant milestone for enGene’s bladder cancer gene therapy candidate, enabling faster review and development.

🧠 Biogen to Advance Investigational SMA Asset to Registrational Studies Positive Phase 1 results prompt progression of once-yearly ASO therapy for SMA to late-stage trials.

🧪 Enveric Biosciences Announces Data on EB-003 Lead compound targets serotonin receptors with the potential to treat depression and neurological conditions without hallucinogenic effects.

🌱 Triple Hair Group Signs Licensing Agreement for Brazil with Aché Strategic expansion into Brazil's $6B hair care market with exclusive rights granted to Aché.

📈 Quantum BioPharma Announces Private Placement $600M private placement to fund innovative treatments for neurodegenerative disorders through Lucid Psycheceuticals Inc.

🧫 Kane Biotech Converts Insider Loan and Reports AGM Results Governance updates and financial restructuring to support ongoing work in wound care and biofilm disruption.

💡 Follow the BioTech Weekly newsletter for more updates on biotech breakthroughs, regulatory milestones, and investment trends in life sciences.

#Biotech #Pharma #LifeSciences #ClinicalTrials #DrugDevelopment #HealthcareInnovation #SMA #CancerResearch #MentalHealth

Disclaimer: This podcast includes content generated with the help of large language models (LLM). Although care has been taken to ensure accuracy, LLMs can sometimes produce incorrect or misleading information. Listeners are advised to independently verify any details, provide feedback, and reach out.